Millions of doses of Moderna’s Covid-19 vaccine found contaminated

Highlights

• 1.63 million doses have black particles suspended in the vials
• The company is looking into the issue to find the root cause

The Japanese government has put a batch of Moderna's Covid-19 vaccine on hold. This is because...

RYOTA TAKEDA ADMITS DINING WITH NTT PRESIDENT; DENIES VIOLATING ETHICS CODE

Highlights –

• Ryota Takeda admits dining with NTT President; denies violating ethics code.
• A weekly magazine Shukan Bunshun posted a report online about the Nov. 11 dining event.
• The Internal Affairs and Communications Ministry and NTT...

TOKYO STOCKS END LITTLE HIGHER ON TUESDAY OVER GAINS BY COVID-19 DRUGMAKERS

Highlights –

• Tokyo stocks end little higher on Tuesday over gains by COVID-19 drugmakers.
• The 225-issue Nikkei Stock Average ended up at 25.31 points.
• TOPIX index of all First Section issues on the TSE ended at 3.00 points.

JAPAN PREMIER ASKS TELECOMMUNICATIONS MINISTER TO ACHIEVE LOWER MOBILE PHONE FEES

Highlights –

• Japan premier asks telecommunications minister to achieve lower mobile phone fees.
• Takeda is aiming for a considerable cut in the same along with the government.
• Heavy mobile data usage in Tokyo of 8,175 yen ($78) for 20 ...

TAKEDA AIMS TO GO PUBLIC IN THE NEXT 5 TO 10 YEARS AFTER BLACKSTONE’S ACQUISITION

Highlights –

• Takeda Pharmaceutical aims to go public in the next 5 to 10 years after Blackstone’s acquisition.
• The unit needs to expand its business overseas in Chinese-speaking markets.
• Takeda plans to sell its drug unit to Bl...

TAKEDA CO. PLANNING TO SELL ITS OTC MEDICINE UNIT TO U.S BLACKSTONE GROUP INC.

Highlights –

• Takeda Co. planning to sell its OTC medicine unit to U.S Blackstone Group Inc.
• Takeda plans on selling the same for around $2.9 billion.
• Takeda aims to reduce its debt of $5.86 billion after its purchase of Shire Plc.

TAKEDA PHARMACEUTICAL CO.RAISED ITS NET PROFIT OUTLOOK FOR THIS YEAR

Highlights –

• Takeda pharmaceutical co. raised its net profit outlook for this year.
• The drug-making company revised its bottom-line outlook to $880 million.
• It also reported an operating profit outlook to $374 million.
• Tak...